CSPC and AstraZeneca Joint Venture: A New Logic for MNCs to “Build Factories” in China
A British pharmaceutical giant has decided to build its most advanced production line in Shijiazhuang, a second-tier city on the North China Plain. On August 5, AstraZeneca and CSPC Pharmaceutical Group (or CSPC) signed an agreement to establish a joint…
Alphamab Oncology and Pathos reach international licensing agreement for TROP2/HER3 bispecific ADC.
On August 4, Alphamab Oncology (“Alphamab”) announced a licensing agreement with Pathos AI (“Pathos”) for its proprietary, “First-in-Class” TROP2/HER3 bispecific antibody-drug conjugate (ADC), JSKN016. Under the…